Key result
Non-invasive mechanical ventilation manages life-threatening noncardiogenic pulmonary edema following amlodipine toxicity.
Why the study?
Noncardiogenic pulmonary edema from calcium channel blocker toxicity is life-threatening and typically managed with invasive ventilation, with limited reports of noninvasive mechanical ventilatory support.
Case Report (n=1)
Noninvasive ventilation can be a viable management strategy for noncardiogenic pulmonary edema secondary to amlodipine toxicity, potentially avoiding the need for invasive ventilation.
Clinicians should consider noncardiogenic pulmonary edema in amlodipine overdose; single case report leaves open incidence and management.
Amlodipine is a dihydropyridine calcium channel blocker that is commonly used in the management of hypertension. Its pharmacological properties give it the advantage of being administered as a single daily dose. This has a positive impact on the patient’s compliance. In contrast, amlodipine overdose represents a significant challenge to the treating clinician. Noncardiogenic pulmonary edema is a rare adverse event associated with toxicity of calcium channel blockers, including amlodipine. It is a life-threatening situation that requires a prompt response. Most reported cases in the literature required invasive ventilation. In this case report, we present a young woman with amlodipine toxicity managed using noninvasive mechanical ventilatory support.
No takes yet. Share an insight, caveat, or question.
Menasri et al. (2024) conducted a case report in Amlodipine toxicity and noncardiogenic pulmonary edema (n=1). Non-invasive ventilation was evaluated. Non-invasive mechanical ventilatory support was used to manage a young woman presenting with life-threatening noncardiogenic pulmonary edema following amlodipine toxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: